Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Validating biotin biosynthesis as a broad-spectrum antimicrobial target

EF 2016-17

Résumé
The rise in antibiotic resistance coupled with the lack of novel antibiotic discovery threatens to create a public health crisis. Current antibiotics target a narrow range of bacterial processes required for their survival. With this in mind, the scope for novel drug discovery can be broadened by increasing the number of targetable processes. Traditionally, when searching for new antibiotics, bacteria are grown in the presence of a surplus of nutrients. However, many of these nutrients are unavailable to bacteria during infection, forcing the bacteria to synthesize the nutrients for themselves. The inhibition of these metabolic pathways is a promising direction to address the limits of existing antibiotics. The biotin (vitamin B7) synthesis pathway is of particular interest due to the discovery of compounds inhibiting the enzyme BioA, an essential component of this pathway. The goal of this research project is to determine if biotin biosynthesis is essential for bacterial survival when infecting a host. The essentiality of the biotin biosynthesis pathway will be defined by comparing the ability of a bacteria to establish an infection when it is unable to synthesize biotin to a regular biotin producing bacteria. As infection can occur within many sites of the body this comparison will be performed in a variety of tissue sites with a range of bacterial species. Upon identification of infection sites where biotin biosynthesis is essential for infection the efficacy of BioA inhibitors will be tested. Overall, validation of the essentiality of biotin biosynthesis during an infection creates a novel target for future drug development.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367063
Name
Carfrae Lindsey A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Validating biotin biosynthesis as a broad-spectrum antimicrobial target
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotic Resistance; Bacterial Physiology; Gene Essentiality; Infectious Disease; Pathogenesis; Target Validation
Abstract
The rise in antibiotic resistance coupled with the lack of novel antibiotic discovery threatens to create a public health crisis. Current antibiotics target a narrow range of bacterial processes required for their survival. With this in mind, the scope for novel drug discovery can be broadened by increasing the number of targetable processes. Traditionally, when searching for new antibiotics, bacteria are grown in the presence of a surplus of nutrients. However, many of these nutrients are unavailable to bacteria during infection, forcing the bacteria to synthesize the nutrients for themselves. The inhibition of these metabolic pathways is a promising direction to address the limits of existing antibiotics. The biotin (vitamin B7) synthesis pathway is of particular interest due to the discovery of compounds inhibiting the enzyme BioA, an essential component of this pathway. The goal of this research project is to determine if biotin biosynthesis is essential for bacterial survival when infecting a host. The essentiality of the biotin biosynthesis pathway will be defined by comparing the ability of a bacteria to establish an infection when it is unable to synthesize biotin to a regular biotin producing bacteria. As infection can occur within many sites of the body this comparison will be performed in a variety of tissue sites with a range of bacterial species. Upon identification of infection sites where biotin biosynthesis is essential for infection the efficacy of BioA inhibitors will be tested. Overall, validation of the essentiality of biotin biosynthesis during an infection creates a novel target for future drug development.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Carfrae, Lindsey A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~